Biotech 2010 to Feature 40 Presentations by Emerging Bioscience Companies

Regional Bioscience Companies to Give Presentations on Their Leading Technologies and Assets on October 27 and 28 at the Pennsylvania Convention Center in Philadelphia

TRENTON, N.J. & WAYNE, Pa.--(BUSINESS WIRE)-- Biotech 2010, the tenth annual joint symposium of BioNJ and Pennsylvania Bio, will feature presentations by more than 40 emerging bioscience companies from across the Mid-Atlantic region. Biotech 2010 will be held October 27-28, 2010, at the Pennsylvania Convention Center in Philadelphia.

These companies, which are interested in raising capital, partnering, or developing strategic connections for their products or technologies, will be presenting to potential investors, partners, and other members of the regional bioscience community. The Company Presentation sessions at Biotech 2010 are sponsored by Deloitte and SNR Denton.

Confirmed presenting companies include:

  • 3D Biotek, LLC
  • AcquiSci Inc.
  • AltheRx, Inc.
  • AngioLab, Inc.
  • Ansaris
  • Applied Separations, Inc.
  • Augmenta Biologicals, LLC
  • BioNanomatrix, Inc.
  • Boryung Pharmaceutical, Ltd
  • Cernostics, Inc.
  • Diamyd Incorporated
  • Discovery Laboratories, Inc.
  • DoseCue
  • Edge Therapeutics Inc.
  • Esperance Pharmaceuticals
  • EyeGene, Inc.
  • Ezose Sciences, Inc.
  • Immunome, Inc.
  • In Silico Biosciences
  • Korea Research Institute of Chemical Technology
  • LZ Therapeutics, Inc.
  • Makefield Therapeutics, Inc.
  • Molecular Detection, Inc.
  • Molecular Targeting Technologies, Inc.
  • NPS Pharmaceuticals
  • Onconova
  • PhaseBio Pharmaceuticals Inc.
  • PhDiagnostics, Inc.
  • Postech-Acornex
  • ProCell Therapeutics Inc.
  • Profectus BioSciences, Inc
  • PTC Therapeutics, Inc.
  • Rational Affinity Devices LLC
  • Recro Pharma, Inc.
  • SK Life Science Inc.
  • TherimuneX Pharmaceuticals
  • Tobira Therapeutics, Inc.
  • Unigene
  • Vicept Therapeutics, Inc.
  • ViroMed Co., Ltd.
  • Vitae Pharmaceuticals, Inc.

More detailed information, including presentation times, company presenters, locations, and company descriptions, can be accessed by visiting the Company Presentations section of www.biotech2010.org.

In addition to the company presentations, Biotech 2010 will also feature panel discussions; keynote addresses by Tommy G. Thompson, former secretary of the U.S. Department of Health of Human Services and Alex Gorsky, worldwide chairman, Medical Devices and Diagnostics Group of Johnson & Johnson; two plenary sessions; Partnering sessions; an Innovation Corridor; and an Exhibit Hall.

About Biotech 2010

Biotech 2010: Imagine. Collaborate. Innovate is designed to advance the growth and development of the bioscience industry in the Mid-Atlantic region. In its tenth year, this event is a joint symposium of BioNJ and Pennsylvania Bio.

Each year the symposium attracts top executives from the region's global pharmaceutical, biotechnology, medical device, and diagnostic companies; venture capitalists and other investors; university researchers; university-industry liaison officers; government officials; and support organizations. For more information, please visit www.biotech2010.org.



CONTACT:

Media Contacts
New Jersey – Bill O’Donnell
609-890-3185
[email protected]
or
Pennsylvania – Amber van Niekerk
610-947-6800 ext. 211
[email protected]

KEYWORDS:   United States  North America  New Jersey  Pennsylvania

INDUSTRY KEYWORDS:   Health  Biotechnology

MEDIA:

Suggested Articles

Almirall is pulling the trigger on an option to advance Dermira's lebrikizumab in Europe, a program it reckons could rake in €450 million.

Acer Therapeutics’ stock plummeted more than 78% premarket this morning on news that the FDA had rejected approval of its drug Edsivo (celiprolol).

The latest setback prompted Novartis-partnered Conatus to lay off 40% of its staff and begin looking for strategic alternatives.